Dapagliflozin in maturity-onset diabetes of the young with HNF1A mutation and diabetic nephropathy

Int Urol Nephrol. 2024 Dec 4. doi: 10.1007/s11255-024-04317-w. Online ahead of print.

Authors

Yu An¹, Huiying Shao¹, Wencui Chen¹, Dandan Liang²

Affiliations

¹ National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, 305 East Zhong Shan Road, Nanjing, 210002, China.
² National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, 305 East Zhong Shan Road, Nanjing, 210002, China. ldd1111@hotmail.com.

PMID: 39630369
DOI: 10.1007/s11255-024-04317-w

No abstract available

Keywords: Diabetic glomerulopathy; Glycosuria; HNF1A; SGLT2 inhibitor.